Array BioPharma, Inc.
| Nasdaq: ARRY
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Its proprietary drug development pipeline is primarily focused on the treatment of cancer and inflammatory disease and includes clinical candidates that are designed to regulate therapeutically important targets. The company also discovers and develops drug candidates across a broad range of therapeutic areas in collaboration with leading pharmaceutical and biotechnology companies such as AstraZeneca, Novartis, InterMune and Roche. Array BioPharma was founded by Kevin Koch, Anthony Piscopio, K.C. Nicolaou and David L. Snitman in 1998 and is headquartered in Boulder, CO.